Overview
Main description
The most comprehensive, widely used, and evidence-based pharmacotherapy text available
Full-color design!
A Doody's Core Title ESSENTIAL PURCHASE for 2011!
5 STAR DOODYS'S REVIEW!
"This is a gold standard reference in pharmacy and the information it provides equips readers with the knowledge base and confidence to provide the highest quality of patient care."--Doody's Review Service
Hailed by Doody's Review Service as "one of the best in pharmacy" Pharmacotherapy: A Pathophysiologic Approach is unmatched in its ability to help students develop a mastery of evidence-based medicine for optimum patient outcomes. The eighth edition will feature the addition of SI units throughout and an increased number of global examples and clinical questions.
Features
- Unparalleled guidance in the development of pharmaceutical care plans
- Full-color presentation
- Key Concepts in each chapter
- Critical Presentation boxes summarize common disease signs and symptoms
- Clinical Controversies boxes examin complicated issues you face when providing drug therapy
- NEW material added to the online learning center
- EXPANDED evidence-based recommendations
- EXPANDED coverage of timely issues such as palliative care and pain medicine
- Therapeutic recommendations in each disease-specific chapter
Table of contents
Section 1: Foundation Issues Section Editor: L. Michael Posey
1. Pharmacoeconomics: Principles, Methods, and Applications
2. Health Outcomes and Quality of Life
3. Health Literacy and Medication Use
4. Cultural Competency
5. Principles and Practices of Medication Safety
6. Evidence Based Medicine
7. Documentation of Pharmacy Services
8. Clinical Pharmacokinetics and Pharmacodynamics
9. Pharmacogenetics
10. Pediatrics
11. Geriatrics
12. Palliative Care
13. Pharmacoepidemiology
14. Clinical Toxicology
15. Emergency Preparedness: Identification and Management of Biologic Exposures
16. Emergency Preparedness: Identification adn Management of Chemical and Radiologic Exposures
Section 2: Cardiovascular Disorders Section Editor: Robert L. Talbert
17. Cardiovascular Testing
18. Cardiac Arrest
19. Hypertension
20. Systolic Heart Failure
21. Diastolic Heart Failure and the Cardiomyopathies
22. Acute Decompensated Heart
23. Ischemic Heart DiseaseJ
24. Acute Coronary Syndromes
25. The Arrhythmias
26. Venous Thromboembolism
27. Stroke
28. Dyslipidemia
29. Peripheral Arterial Disease
30. Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock
31. Hypovolemic Shock
Section 3: Respiratory Disorders Section Editor: Robert L. Talbert
32. Introduction to Pulmonary Function Testing
33. Asthma
34. Chronic Obstructive Pulmonary Disease
35. Pulmonary Hypertension
36. Drug-Induced Pulmonary Diseases
37. Cystic Fibrosis
Section 4: Gastrointestinal Disorders Section Editor: Joseph T. DiPiro
38. Evaluation of the Gastrointestinal Tract
39. Gastroesophageal Reflux Disease
40. Peptic Ulcer Disease
41. Inflammatory Bowel Disease
42. Nausea and Vomiting
43. Diarrhea, Constipation, and Irritable Bowel Syndrome
44. Portal Hypertension and Cirrhosis
45. Drug-Induced Liver Disease
46. Pancreatitis
47. Viral Hepatitis
48. Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity
49. Celiac Disease
Section 5: Renal Disorders Section Editor: Gary R. Matzke
50. Clinical Assessment of Kidney Function
51. Acute Kidney Injury
52. Chronic Kidney Disease: Progression-Modifying Therapies
53. Chronic Kidney Disease: Management of Complications
54. Hemodialysis and Peritoneal Dialysis
55. Drug-Induced Kidney Disease
56. Glomerulonephritis
57. Drug Therapy Individualization for Patients with Renal Insufficiency
58. Disorders of Sodium and Water Homeostasis
59. Disorders of Calcium and Phosphorus Homeostasis
60. Disorders of Potassium and Magnesium Homeostasis Donald F. Brophy and Todd W. B. Gehr
61. Acid-Base Disorders
Section 6: Neurologic Disorders Section Editor: Barbara G. Wells
62. Evaluation of Neurologic Illness
63. Alheimer's Disease
64. Multiple Sclerosis
65. Epilepsy
66. Status Epilepticus
67. Acute Management of the Brain Injury Patient
68. Parkinson's Disease
69. Pain Management
70. Headache Disorders
Section 7: Psychiatric Disorders Section Editor: Barbara G. Wells
71. Evaluation of Psychiatric Illness
72. Childhood Disorders
73. Eating Disorders
74. Substance Related Disroders: Overview and Depressahts, Stimulants and Hallucinogens
75. Substance-Related Disorders: Alcohol, Nicotine, and Caffeine
76. Schizophrenia
77. Major Depressive Disorders
78. Bipolar Disorder
79. Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders
80. Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder
81. Sleep Disorders
82. Disorders Associated with Intellectual Disabilities
Author comments
Author Profiles
Joseph DiPiro, PharmD, FCCP
Executive Dean and Professor,
South Carolina School of Pharmacy
Robert Talbert, PharmD, FCCP, BCPS
Professor
University of Texas, Health Science Center
Gary Yee, PharmD, FCCP
Professor and Associate Dean for Academic Affairs
University of Nebraska, Medical Center
Gary Matzke, PharmD, FCP, FCCP
Professor and Associate Dean for Clinical Research and Public Policy
Virginia Commonwealth University School of Clinical Research and Public Policy
Barbara Wells, PharmD, FASHP, FCCP, BCPP
Dean and Professor, Executive Director of the Research Institute of Phamaceutical Sciences
University of Mississippi School of Pharmacy
L. Michael Posey, BS Pharm
Editorial Director
American Pharmacists Association
